{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:22:11Z","timestamp":1780683731717,"version":"3.54.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Decreased efficacy of artemisinin-based combination therapy (ACT) for\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      malaria has been previously reported in patients with sickle cell disease (SCD). The main purpose of this study was to investigate the in vitro susceptibility of isolates to dihydro-artemisinin (DHA) to provide a hypothesis to explain this treatment failure.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Isolates were collected from patients attending health centres in Abidjan with uncomplicated\n                      <jats:italic>P<\/jats:italic>\n                      <jats:italic>. falciparum<\/jats:italic>\n                      malaria. The haemoglobin type has been identified and in vitro drug sensitivity tests were conducted with the ring stage assay and maturation inhibition assay.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>134 isolates were obtained. Parasitaemia and haemoglobin levels at inclusion were lower in patients with haemoglobin HbSS and HbSC than in patients with normal HbAA. After ex vivo RSA and drug inhibition assays, the lowest rate of parasitic growth was found with isolates from HbAS red cells. Conversely, a significantly higher survival rate of parasites ranging from 15 to 34% were observed in isolates from HbSS. Isolates with in vitro reduced DHA sensitivity correlate with lower RBC count and haematocrit and higher parasitaemia at inclusion compared to those with isolates with normal DHA sensitivity. However, this decrease of in vitro sensitivity to DHA was not associated with Kelch 13-Propeller gene polymorphism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study highlights an in vitro decreased sensitivity to DHA, for isolates collected from HbSS patients, not related to the Pfkelch13 gene mutations. These results are in line with recent studies pointing out the role of the redox context in the efficacy of the drug. Indeed, SCD red cells harbour a highly different ionic and redox context in comparison with normal red cells. This study offers new insights into the understanding of artemisinin selective pressure on the malaria parasite in the context of haemoglobinopathies in Africa.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-023-04819-5","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T11:01:38Z","timestamp":1704366098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In vitro delayed response to dihydroartemisinin of malaria parasites infecting sickle cell erythocytes"],"prefix":"10.1186","volume":"23","author":[{"given":"Albert A.","family":"Gnondjui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Offianan A.","family":"Toure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berenger A.","family":"Ako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tossea S.","family":"Koui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas E.","family":"Assohoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Gbessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landry T.","family":"N\u2019Guessan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Tuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Beourou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge-Brice","family":"Assi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis A.","family":"Yapo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahima","family":"Sanogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Jambou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"4819_CR1","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/j.ijid.2009.03.010","volume":"14","author":"C Booth","year":"2010","unstructured":"Booth C, Inusa B, Obaro SK. Infection in sickle cell disease: a review. Int J Infect Dis. 2010;14:e2\u201312.","journal-title":"Int J Infect Dis"},{"key":"4819_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1182\/blood-2009-07-233528","volume":"115","author":"J Makani","year":"2010","unstructured":"Makani J, Komba AN, Cox SE, Oruo J, Mwamtemi K, Kitundu J, et al. Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization. Blood. 2010;115:215\u201320.","journal-title":"Blood"},{"key":"4819_CR3","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","volume":"376","author":"DC Rees","year":"2010","unstructured":"Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376:2018\u201331.","journal-title":"Lancet"},{"key":"4819_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/icb.1992.34","volume":"70","author":"KM Naumann","year":"1992","unstructured":"Naumann KM, Jones GL, Saul A, Ross S. Parasite-induced changes to localized erythrocyte membrane deformability in Plasmodium falciparum cultures. Immunol Cell Biol. 1992;70:267\u201375.","journal-title":"Immunol Cell Biol"},{"key":"4819_CR5","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/S0140-6736(04)17192-4","volume":"364","author":"MJ Stuart","year":"2004","unstructured":"Stuart MJ, Nagel RL. Sickle-cell disease. Lancet. 2004;364:1343\u201360.","journal-title":"Lancet"},{"key":"4819_CR6","first-page":"704","volume":"79","author":"DJ Weatherall","year":"2001","unstructured":"Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79:704\u201312.","journal-title":"Bull World Health Organ"},{"key":"4819_CR7","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.3324\/haematol.2011.047365","volume":"96","author":"D Nebor","year":"2011","unstructured":"Nebor D, Bowers A, Hardy-Dessources M-D, Knight-Madden J, Romana M, Reid H, et al. Frequency of pain crises in sickle cell anemia and its relationship with the sympatho-vagal balance, blood viscosity and inflammation. Haematologica. 2011;96:1589\u201394.","journal-title":"Haematologica"},{"key":"4819_CR8","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1001\/jama.2015.3075","volume":"313","author":"N Stettler","year":"2015","unstructured":"Stettler N, McKiernan CM, Melin CQ, Adejoro OO, Walczak NB. Proportion of adults with sickle cell anemia and pain crises receiving hydroxyurea. JAMA. 2015;313:1671\u20132.","journal-title":"JAMA"},{"key":"4819_CR9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1136\/bmj.330.7489.432","volume":"330","author":"GR Serjeant","year":"2005","unstructured":"Serjeant GR. Mortality from sickle cell disease in Africa. BMJ. 2005;330:432\u20133.","journal-title":"BMJ"},{"key":"4819_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1086\/430744","volume":"192","author":"TN Williams","year":"2005","unstructured":"Williams TN, Mwangi TW, Wambua S, Alexander ND, Kortok M, Snow RW, et al. Sickle celle trait and the risk of Plasmodium falciparum malaria and other childhood diseases. J Infect Dis. 2005;192:178\u201386.","journal-title":"J Infect Dis"},{"key":"4819_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.mib.2006.06.009","volume":"9","author":"TN Williams","year":"2006","unstructured":"Williams TN. Human red blood cell polymorphisms and malaria. Curr Opin Microbiol. 2006;9:388\u201394.","journal-title":"Curr Opin Microbiol"},{"key":"4819_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014699","volume":"6","author":"J Makani","year":"2011","unstructured":"Makani J, Cox SE, Soka D, Komba AN, Oruo J, Mwamtemi H, et al. Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania. PLoS ONE. 2011;6: e14699.","journal-title":"PLoS ONE"},{"key":"4819_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.pt.2011.02.004","volume":"27","author":"TN Williams","year":"2011","unstructured":"Williams TN, Obaro SK. Sickle cell disease and malaria morbidity: a tale with two tails. Trends Parasitol. 2011;27:315\u201320.","journal-title":"Trends Parasitol"},{"key":"4819_CR14","doi-asserted-by":"publisher","first-page":"7049","DOI":"10.1128\/AAC.02746-14","volume":"58","author":"K Thriemer","year":"2014","unstructured":"Thriemer K, Van Hong N, Rosanas-Urgell A, Phuc BQ, Ha DM, Pockele E, et al. Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in central Vietnam. Antimicrob Agents Chemother. 2014;58:7049\u201355.","journal-title":"Antimicrob Agents Chemother"},{"key":"4819_CR15","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1186\/s13071-015-1253-z","volume":"8","author":"B Huang","year":"2015","unstructured":"Huang B, Deng C, Yang T, Xue L, Wang Q, Huang S, et al. Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy. Parasit Vectors. 2015;8:634.","journal-title":"Parasit Vectors"},{"key":"4819_CR16","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1086\/421330","volume":"74","author":"J Ohashi","year":"2004","unstructured":"Ohashi J, Naka I, Patarapotikul J, Hananantachai H, Brittenham G, Looareesuwan S, et al. Extended linkage disequilibrium surrounding the haemoglobin E variant due to malarial selection. Am J Hum Genet. 2004;74:1198\u2013208.","journal-title":"Am J Hum Genet"},{"key":"4819_CR17","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1128\/AAC.01636-09","volume":"54","author":"B Witkowski","year":"2010","unstructured":"Witkowski B, Lelievre J, Lopez Barragan MJ, Laurent V, Su XZ, Berry A, et al. Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism. Antimicrob Agents Chemother. 2010;54:1872\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"4819_CR18","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1093\/jac\/dkaa250","volume":"75","author":"T Reyser","year":"2020","unstructured":"Reyser T, Paloque L, Ouji M, Nguyen M, M\u00e9nard S, Witkowski B, et al. Identification of compounds active against quiescent artemisinin-resistant Plasmodium falciparum parasites via the quiescent-stage survival assay (QSA). J Antimicrob Chemother. 2020;75:2826\u201334.","journal-title":"J Antimicrob Chemother"},{"key":"4819_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A-C, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"4819_CR20","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1038\/s41598-020-60549-7","volume":"10","author":"GM Bwire","year":"2020","unstructured":"Bwire GM, Ngasala B, Mikomangwa WP, Kilonzi M, Kamuhabwa AAR. Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania. Sci Rep. 2020;10:3500.","journal-title":"Sci Rep"},{"key":"4819_CR21","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","volume":"21","author":"A Uwimana","year":"2021","unstructured":"Uwimana A, Umulisa N, Venkatesan M, Svigel SS, Zhou Z, Munyaneza T, et al. Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study. Lancet Infect Dis. 2021;21:1120\u20138.","journal-title":"Lancet Infect Dis"},{"key":"4819_CR22","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/infdis\/jiaa687","volume":"223","author":"V Asua","year":"2021","unstructured":"Asua V, Conrad MD, Aydemir O, Duvalsaint M, Legac J, Duarte E, et al. Changing prevalence of potential mediators of aminoquinoline, antifolate, and artemisinin resistance across Uganda. J Infect Dis. 2021;223:985\u201394.","journal-title":"J Infect Dis"},{"key":"4819_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijpddr.2021.06.001","volume":"16","author":"L Ndwiga","year":"2021","unstructured":"Ndwiga L, Kimenyi KM, Wamae K, Osoti V, Akinyi M, Omedo I, et al. A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa. Int J Parasitol Drugs Drug Resist. 2021;16:155\u201361.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"4819_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0163-7258(82)90070-5","volume":"18","author":"JS Wiley","year":"1982","unstructured":"Wiley JS, McCulloch KE. Calcium ions, drug action and the red cell membrane. Pharmacol Ther Dent. 1982;18:271\u201392.","journal-title":"Pharmacol Ther Dent"},{"key":"4819_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/869401","volume":"2014","author":"S Cheemadan","year":"2014","unstructured":"Cheemadan S, Ramadoss R, Bozdech Z. Role of calcium signaling in the transcriptional regulation of the apicoplast genome of Plasmodium falciparum. Biomed Res Int. 2014;2014: 869401.","journal-title":"Biomed Res Int"},{"key":"4819_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bcmd.2011.01.002","volume":"46","author":"A Gizi","year":"2011","unstructured":"Gizi A, Papassotiriou I, Apostolakou F, Lazaropoulou C, Papastamataki M, Kanavaki I, et al. Assessment of oxidative stress in patients with sickle cell disease: the glutathione system and the oxidant\u2013antioxidant status. Blood Cells Mol Dis. 2011;46:220\u20135.","journal-title":"Blood Cells Mol Dis"},{"key":"4819_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.freeradbiomed.2013.11.022","volume":"67","author":"RV Zwieten","year":"2014","unstructured":"Zwieten RV, Vherhoeven AJ, Roos D. Inborn defects in the antioxidant systems of human red blood cells. Free Radic Biol Med. 2014;67:377\u201386.","journal-title":"Free Radic Biol Med"},{"key":"4819_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1046\/j.1365-2141.2003.04781.x","volume":"124","author":"B Tinku","year":"2004","unstructured":"Tinku B, Kuypers FA. Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells. Br J Haematol. 2004;124:391\u2013402.","journal-title":"Br J Haematol"},{"key":"4819_CR29","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.3390\/antiox10121872","volume":"10","author":"CO Egwu","year":"2021","unstructured":"Egwu CO, Augereau JM, Reybier K, Benoit-Vical F. Reactive oxygen species as the brainbox in malaria treatment. Antioxidants. 2021;10:1872.","journal-title":"Antioxidants"},{"key":"4819_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.freeradbiomed.2021.03.001","volume":"167","author":"CO Egwu","year":"2021","unstructured":"Egwu CO, Ioannis T, P\u00e9rio P, Augereau JM, Benoit-Vical F, Reybier K. Superoxide: a major role in the mechanism of action of essential antimalarial drugs. Free Radic Biol Med. 2021;167:271\u20135.","journal-title":"Free Radic Biol Med"},{"key":"4819_CR31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13071-018-2762-3","volume":"11","author":"T Adams","year":"2018","unstructured":"Adams T, Ennuson NAA, Quashie NB, Futagbi G, Matrevi S, Hagan OCK, et al. Prevalence of Plasmodium falciparum delayed clearance associated polymorphisms in adaptor protein complex 2 mu subunit (pfap2mu) and ubiquitin specific protease 1 (pfubp1) genes in Ghanaian isolates. Parasit Vectors. 2018;11:175.","journal-title":"Parasit Vectors"},{"key":"4819_CR32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ng.3189","volume":"47","author":"O Miotto","year":"2015","unstructured":"Miotto O, Amato R, Ashley EA, Macinnis B, Almagro-Garcia J, Amaratunga C, et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat Genet. 2015;47:226\u201334.","journal-title":"Nat Genet"},{"key":"4819_CR33","first-page":"e01542","volume":"64","author":"RC Henrici","year":"2020","unstructured":"Henrici RC, Van-Schalkwyk DA, Sutherland CJ. Modification of pfap2\u03bc and pfubp1 markedly reduces ring-stage susceptibility of Plasmodium falciparum to artemisinin in vitro. Antimicrob Agents Chemother. 2020;64:e01542-e1619.","journal-title":"Antimicrob Agents Chemother"},{"key":"4819_CR34","doi-asserted-by":"publisher","first-page":"e08714","DOI":"10.7554\/eLife.08714","volume":"5","author":"R Amato","year":"2016","unstructured":"Amato R, Campino S, Mead D, Drury E, Kekre M, Sanders M, et al. Genomic epidemiology of artemisinin resistant malaria. Elife. 2016;5:e08714.","journal-title":"Elife"},{"key":"4819_CR35","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1093\/infdis\/jiu358","volume":"210","author":"G Henriques","year":"2014","unstructured":"Henriques G, Hallett RL, Beshir KB, Gadalla NB, Johnson RE, Burrow R, et al. Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT. J Infect Dis. 2014;210:2001\u20138.","journal-title":"J Infect Dis"},{"key":"4819_CR36","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s13104-018-3296-7","volume":"11","author":"SK Tossea","year":"2018","unstructured":"Tossea SK, Adji EG, Coulibaly B, Ako BA, Coulibaly DN, Joly P, et al. Cross sectional study on prevalence of sickle cell alleles S and C among patients with mild malaria in Ivory Coast. BMC Res Notes. 2018;11:215.","journal-title":"BMC Res Notes"},{"key":"4819_CR37","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","volume":"374","author":"D M\u00e9nard","year":"2016","unstructured":"M\u00e9nard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, et al. A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N Engl J Med. 2016;374:2453\u201364.","journal-title":"N Engl J Med"},{"key":"4819_CR38","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/1475-2875-13-369","volume":"13","author":"GO Adjei","year":"2014","unstructured":"Adjei GO, Goka BQ, Enweronu-Laryea CC, Rodrigues OP, Renner L, Sulley AM, et al. A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria. Malar J. 2014;13:369.","journal-title":"Malar J"},{"key":"4819_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1051\/parasite\/2021063","volume":"28","author":"EA Gbessi","year":"2021","unstructured":"Gbessi EA, Toure OA, Gnondjui A, Koui TS, Coulibaly B, Ako BA, et al. Artemisinin derivative-containing therapies and abnormal hemoglobin: do we need to adapt the treatment? Parasite. 2021;28:67\u201377.","journal-title":"Parasite"},{"key":"4819_CR40","doi-asserted-by":"publisher","DOI":"10.4000\/anthropologiesante.884","author":"A Lain\u00e9","year":"2012","unstructured":"Lain\u00e9 A, Diallo D, Traor\u00e9 B. De Koloci \u00e0 la dr\u00e9panocytose. Anthropologie et Sant\u00e9. 2012. https:\/\/doi.org\/10.4000\/anthropologiesante.884.","journal-title":"Anthropologie et Sant\u00e9"},{"key":"4819_CR41","first-page":"7","volume":"26","author":"S Douamba","year":"2017","unstructured":"Douamba S, Nagalo K, Tamini L, Traor\u00e9 I, Kam M, Kou\u00e9ta F, et al. [Major sickle cell syndromes and infections associated with this condition in children in Burkina Faso.](in French). Pan Afr Med J. 2017;26:7.","journal-title":"Pan Afr Med J."},{"key":"4819_CR42","first-page":"63","volume":"20","author":"A Tolo-Diebkil\u00e9","year":"2010","unstructured":"Tolo-Diebkil\u00e9 A, Koffi KG, Nanho DC, Sawadogo D, Kouakou B, Siransy-Bogui L, et al. Dr\u00e9panocytose homozygote chez l\u2019adulte ivoirien de plus de 21 ans. Sante. 2010;20:63\u20137.","journal-title":"Sante"},{"key":"4819_CR43","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/273860","volume":"2014","author":"D Sawadogo","year":"2014","unstructured":"Sawadogo D, Tolo-Dilk\u00e9bi\u00e9 A, Sangar\u00e9 M, Agu\u00e9hound\u00e9 N, Kassi H, Latte T. Influence of the clinical status on stress reticulocytes, CD 36 and CD 49d of SSFA 2 homozygous sickle cell patients followed in Abidjan. Adv Hematol. 2014;2014: 273860.","journal-title":"Adv Hematol"},{"key":"4819_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003780","volume":"3","author":"A Esposito","year":"2008","unstructured":"Esposito A, Tiffert T, Mauritz JMA, Schlachter S, Bannister LH, Kaminski CF, et al. FRET imaging of hemoglobin concentration in Plasmodium falciparum-infected red cells. PLoS One. 2008;3: e3780.","journal-title":"PLoS One"},{"key":"4819_CR45","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","volume":"13","author":"B Witkowski","year":"2013","unstructured":"Witkowski B, Amaratunga C, Khim N, Sreng S, Chim P, Kim S, et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet Infect Dis. 2013;13:1043\u20139.","journal-title":"Lancet Infect Dis"},{"key":"4819_CR46","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1128\/AAC.03055-14","volume":"58","author":"C Amaratunga","year":"2014","unstructured":"Amaratunga C, Witkowski B, Dek D, Try V, Khim N, Miotto O, et al. Plasmodium falciparum founder populations in Western Cambodia have reduced artemisinin sensitivity in vitro. Antimicrob Agents Chemother. 2014;58:4935\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"4819_CR47","first-page":"883","volume":"6","author":"JB Jensen","year":"1976","unstructured":"Jensen JB, Trager W. Plasmodium falciparum in culture\u202f: use of outdated erythrocytes and description of the candle jar method. J Parasitol. 1976;6:883\u20136.","journal-title":"J Parasitol"},{"key":"4819_CR48","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1046\/j.1472-8206.2003.00164.x","volume":"17","author":"J Le Bras","year":"2003","unstructured":"Le Bras J, Durand R. The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum. Fundam Clin Pharmacol. 2003;17:147\u201353.","journal-title":"Fundam Clin Pharmacol"},{"key":"4819_CR49","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","volume":"48","author":"M Smilkstein","year":"2004","unstructured":"Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother. 2004;48:1803\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"4819_CR50","unstructured":"Basco LK. Field application of in vitro assays for the sensitivity of human malaria parasites to antimalarial drugs. 2007. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/ 43610\/9789241595155_eng.pdf"},{"key":"4819_CR51","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cmpb.2010.08.003","volume":"104","author":"H Le Nagard","year":"2011","unstructured":"Le Nagard H, Vincent C, Mentr\u00e9 F, Le Bras J. Online analysis of in vitro resistance to antimalarial drugs through nonlinear regression. Comput Methods Programs Biomed. 2011;104:10\u20138.","journal-title":"Comput Methods Programs Biomed"},{"key":"4819_CR52","doi-asserted-by":"publisher","first-page":"6952","DOI":"10.1128\/AAC.01255-15","volume":"59","author":"Z Wang","year":"2015","unstructured":"Wang Z, Wang Y, Cabrera M, Zhang Y, Gupta B, Wu Y, et al. Artemisinin resistance at the China-Myanmar border and association with mutations in the K13 propeller gene. Antimicrob Agents Chemother. 2015;59:6952\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl","key":"4819_CR53","first-page":"52","volume":"30","author":"Y Wu","year":"2001","unstructured":"Wu Y, Fairfield AS, Oduola A, Cypess RH, MR4 Scientific Advisory Committee. The malaria research and reference reagent resource (MR4) center-creating African opportunities. Afr J Med Medic Sci. 2001;30(Suppl):52\u20134.","journal-title":"Afr J Med Medic Sci"},{"key":"4819_CR54","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"4819_CR55","first-page":"1534","volume":"54","author":"F Galact\u00e9ros","year":"2004","unstructured":"Galact\u00e9ros F. Physiopathologie de la dr\u00e9panocytose, de la th\u00e9orie aux aspects pratiques. Rev Prat. 2004;54:1534\u201342.","journal-title":"Rev Prat"},{"key":"4819_CR56","first-page":"220","volume":"2","author":"D Labie","year":"2005","unstructured":"Labie D, Elion J. Bases mol\u00e9culaires et physiopathologiques des maladies de l\u2019h\u00e9moglobine. Encyclopedie Medico-Chirurgicale H\u00e9matolgie. 2005;2:220\u201339.","journal-title":"Encyclopedie Medico-Chirurgicale H\u00e9matolgie"},{"key":"4819_CR57","first-page":"679","volume":"69","author":"S Huynh-Moynot","year":"2011","unstructured":"Huynh-Moynot S, Moynot JC, Commandeur D, Des Deserts MD, Montelescaut \u00c9, Kenane N, et al. Dr\u00e9panocytose: des aspects mo\u013aculaires \u00e0 la pratique clinique. \u00c0 propos d\u2019un cas et revue de la litt\u0301rature. Ann Biol Clin. 2011;69:679\u201384.","journal-title":"Ann Biol Clin."},{"key":"4819_CR58","doi-asserted-by":"publisher","first-page":"S398","DOI":"10.1016\/j.amepre.2011.09.013","volume":"41","author":"SD Grosse","year":"2011","unstructured":"Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN. Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med. 2011;41:S398\u2013405.","journal-title":"Am J Prev Med"},{"key":"4819_CR59","doi-asserted-by":"publisher","first-page":"021103","DOI":"10.7189\/jogh.08.021103","volume":"8","author":"E Wastnedge","year":"2018","unstructured":"Wastnedge E, Waters D, Patel S, Morrison K, Goh MY, Adeloye D, et al. The global burden of sickle cell disease in children under five years of age: a systematic review and meta-analysis. J Glob Health. 2018;8:021103.","journal-title":"J Glob Health"},{"key":"4819_CR60","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1186\/s12879-020-05625-z","volume":"20","author":"P Kosiyo","year":"2020","unstructured":"Kosiyo P, Otieno W, Gitaka J, Munde EO, Ouma C. Association between haematological parameters and sickle cell genotypes in children with Plasmodium falciparum malaria resident in Kisumu County in Western Kenya. BMC Infect Dis. 2020;20:887.","journal-title":"BMC Infect Dis"},{"key":"4819_CR61","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12879-021-06025-7","volume":"21","author":"P Kosiyo","year":"2021","unstructured":"Kosiyo P, Otieno W, Gitaka J, Munde EO, Ouma C. Haematological abnormalities in children with sickle cell disease and non-severe malaria infection in western Kenya. BMC Infect Dis. 2021;21:329.","journal-title":"BMC Infect Dis"},{"key":"4819_CR62","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1038\/s41467-021-21814-z","volume":"12","author":"H Cao","year":"2021","unstructured":"Cao H, Antonopoulos A, Henderson S, Wassall H, Brewin J, Masson A, et al. Red blood cell mannoses as phagocytic ligands mediating both sickle cell anaemia and malaria resistance. Nat Commun. 2021;12:1792.","journal-title":"Nat Commun"},{"key":"4819_CR63","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1152\/physrev.00052.2003","volume":"85","author":"VL Lew","year":"2005","unstructured":"Lew VL, Bookchin RM. Ion transport pathology in the mechanism of sickle cell dehydration. Physiol Rev. 2005;85:179\u2013200.","journal-title":"Physiol Rev"},{"key":"4819_CR64","doi-asserted-by":"publisher","first-page":"7350","DOI":"10.1073\/pnas.1804388115","volume":"115","author":"NM Archer","year":"2018","unstructured":"Archer NM, Petersen N, Clark MA, Buckee CO, Childs LM, Duraisingh MT. Resistance to Plasmodium falciparum in sickle cell trait erythrocytes is driven by oxygen-dependent growth inhibition. Proc Natl Acad Sci USA. 2018;115:7350\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4819_CR65","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cub.2010.04.051","volume":"20","author":"S Glushakova","year":"2010","unstructured":"Glushakova S, Humphrey G, Leikina E, Balaban A, Miller J, Zimmerberg J. New stages in the program of malaria parasite egress imaged in normal and sickle erythrocytes. Curr Biol. 2010;20:1117\u201321.","journal-title":"Curr Biol"},{"key":"4819_CR66","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1182\/blood.V67.4.997.997","volume":"67","author":"JA Olson","year":"1986","unstructured":"Olson JA, Nagel RL. Synchronized cultures of P falciparum in abnormal red cells: the mechanism of the inhibition of growth in HbCC cells. Blood. 1986;67:997\u20131001.","journal-title":"Blood"},{"key":"4819_CR67","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/324364a0","volume":"324","author":"K Rangachari","year":"1986","unstructured":"Rangachari K, Dluzewski A, Wilson RJM, Gratzer WB. Control of malarial invasion by phosphorylation of the host cell membrane cytoskeleton. Nature. 1986;324:364\u20135.","journal-title":"Nature"},{"key":"4819_CR68","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1086\/656476","volume":"202","author":"F Teuscher","year":"2010","unstructured":"Teuscher F, Gatton ML, Chen N, Peters J, Kyle DE, Cheng Q. Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure. J Infect Dis. 2010;202:1362\u20138.","journal-title":"J Infect Dis"},{"key":"4819_CR69","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.3201\/eid2110.150682","volume":"21","author":"S M\u00e9nard","year":"2015","unstructured":"M\u00e9nard S, Ben Haddou T, Ramadani AP, Ariey F, Iriart X, Beghain J, et al. Induction of multidrug tolerance in Plasmodium falciparum by extended artemisinin pressure. Emerg Infect Dis. 2015;21:1733\u201341.","journal-title":"Emerg Infect Dis"},{"key":"4819_CR70","unstructured":"WHO. Artemisinin and artemisinin-based combination therapy resistance: status report 2016. Geneva, World Health Organization, 2016. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/250294\/WHO-HTM-GMP-2016.11-eng.pdf"},{"key":"4819_CR71","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1186\/s12936-016-1622-x","volume":"15","author":"S Menard","year":"2016","unstructured":"Menard S, Tchoufack JN, Maffo CN, Nsango SE, Iriart X, Abate L, et al. Insight into k13-propeller gene polymorphism and ex vivo DHA-response profiles from Cameroonian isolates. Malar J. 2016;15:572.","journal-title":"Malar J"},{"key":"4819_CR72","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3201\/eid2404.170141","volume":"24","author":"M Ikeda","year":"2018","unstructured":"Ikeda M, Kaneko M, Tachibana S-I, Balikagala B, Sakurai-Yatsushiro M, Yatsushiro S, et al. Artemisinin-resistant Plasmodium falciparum with high survival rates, Uganda, 2014\u20132016. Emerg Infect Dis. 2018;24:718\u201326.","journal-title":"Emerg Infect Dis"},{"key":"4819_CR73","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12936-017-1845-5","volume":"16","author":"A Mukherjee","year":"2017","unstructured":"Mukherjee A, Bopp S, Magistrado P, Wong W, Daniels R, Demas A, et al. Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia. Malar J. 2017;16:195.","journal-title":"Malar J"},{"key":"4819_CR74","doi-asserted-by":"publisher","first-page":"11405","DOI":"10.1073\/pnas.1104063108","volume":"108","author":"N Klonis","year":"2011","unstructured":"Klonis N, Crespo-Ortiz MP, Bottova I, Abu-Bakar N, Kenny S, Rosenthal PJ, et al. Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion. P Proc Natl Acad Sci USA. 2011;108:11405\u201310.","journal-title":"P Proc Natl Acad Sci USA"},{"key":"4819_CR75","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/infdis\/jiy188","volume":"218","author":"FA Siddiqui","year":"2018","unstructured":"Siddiqui FA, Cabrera M, Wang M, Brashear A, Kemirembe K, Wang Z, et al. Plasmodium falciparum falcipain-2a polymorphisms in Southeast Asia and their association with artemisinin resistance. J Infect Dis. 2018;218:434\u201342.","journal-title":"J Infect Dis"},{"key":"4819_CR76","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1128\/AAC.00835-15","volume":"59","author":"R Leang","year":"2015","unstructured":"Leang R, Taylor WRJ, Bouth DM, Song L, Tarning J, Char MC, et al. Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in Western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment. Antimicrob Agents Chemother. 2015;59:4719\u201326.","journal-title":"Antimicrob Agents Chemother"},{"key":"4819_CR77","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ng.2624","volume":"45","author":"O Miotto","year":"2013","unstructured":"Miotto O, Almagro-Garcia J, Manske M, MacInnis B, Campino S, Rockett KA, et al. Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet. 2013;45:648\u201355.","journal-title":"Nat Genet"},{"key":"4819_CR78","doi-asserted-by":"publisher","first-page":"11672","DOI":"10.1073\/pnas.1507142112","volume":"112","author":"S Pelleau","year":"2015","unstructured":"Pelleau S, Moss EL, Dhingra SK, Volney B, Casteras J, Gabryszewski SJ, et al. Adaptive evolution of malaria parasites in French Guiana: Reversal of chloroquine resistance by acquisition of a mutation in pfcrt. Proc Natl Acad Sci USA. 2015;112:11672\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4819_CR79","first-page":"1352","volume":"211","author":"E Kamau","year":"2014","unstructured":"Kamau E, Campino S, Amenga-Etego L, Drury E, Ishengoma D, Johnson K, et al. K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa. J Infect Dis. 2014;211:1352\u20135.","journal-title":"J Infect Dis"},{"key":"4819_CR80","doi-asserted-by":"publisher","first-page":"fuaa056","DOI":"10.1093\/femsre\/fuaa056","volume":"45","author":"CJ Sutherland","year":"2021","unstructured":"Sutherland CJ, Henrici RC, Artavanis-Tsakonas K. Artemisinin susceptibility in the malaria parasite Plasmodium falciparum: propellers, adaptor proteins and the need for cellular healing. FEMS Microbiol Revi. 2021;45:fuaa056.","journal-title":"FEMS Microbiol Revi"},{"key":"4819_CR81","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1126\/science.1260403","volume":"347","author":"S Mok","year":"2015","unstructured":"Mok S, Ashley EA, Ferreira PE, Zhu L, Lin Z, Yeo T, et al. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance. Science. 2015;347:431\u20135.","journal-title":"Science"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-023-04819-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-023-04819-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-023-04819-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T07:43:49Z","timestamp":1730965429000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-023-04819-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4819"],"URL":"https:\/\/doi.org\/10.1186\/s12936-023-04819-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2971280\/v1","asserted-by":"object"}]},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"assertion":[{"value":"23 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project received agreement from the National Ethic Committee of Ivory Coast. Patients gave their written consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"NA No personal data is presented in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}